Sodium in PDB 8v6m: Inactivated-State Cryo-Em Structure of Human TRPV3 in Presence of Tetrahydrocannabivarin (Thcv) in CNW30 Nanodiscs
Sodium Binding Sites:
The binding sites of Sodium atom in the Inactivated-State Cryo-Em Structure of Human TRPV3 in Presence of Tetrahydrocannabivarin (Thcv) in CNW30 Nanodiscs
(pdb code 8v6m). This binding sites where shown within
5.0 Angstroms radius around Sodium atom.
In total 3 binding sites of Sodium where determined in the
Inactivated-State Cryo-Em Structure of Human TRPV3 in Presence of Tetrahydrocannabivarin (Thcv) in CNW30 Nanodiscs, PDB code: 8v6m:
Jump to Sodium binding site number:
1;
2;
3;
Sodium binding site 1 out
of 3 in 8v6m
Go back to
Sodium Binding Sites List in 8v6m
Sodium binding site 1 out
of 3 in the Inactivated-State Cryo-Em Structure of Human TRPV3 in Presence of Tetrahydrocannabivarin (Thcv) in CNW30 Nanodiscs
Mono view
Stereo pair view
|
A full contact list of Sodium with other atoms in the Na binding
site number 1 of Inactivated-State Cryo-Em Structure of Human TRPV3 in Presence of Tetrahydrocannabivarin (Thcv) in CNW30 Nanodiscs within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Na905
b:44.5
occ:1.00
|
O
|
A:GLY638
|
2.5
|
37.3
|
1.0
|
O
|
D:GLY638
|
2.5
|
46.0
|
1.0
|
O
|
C:GLY638
|
2.5
|
35.7
|
1.0
|
O
|
B:GLY638
|
2.5
|
36.9
|
1.0
|
HA
|
A:LEU639
|
3.4
|
37.5
|
1.0
|
C
|
A:GLY638
|
3.4
|
37.3
|
1.0
|
HA
|
D:LEU639
|
3.4
|
46.0
|
1.0
|
C
|
C:GLY638
|
3.4
|
35.7
|
1.0
|
HA
|
C:LEU639
|
3.4
|
36.4
|
1.0
|
C
|
D:GLY638
|
3.4
|
46.0
|
1.0
|
HA
|
B:LEU639
|
3.5
|
37.1
|
1.0
|
C
|
B:GLY638
|
3.5
|
36.9
|
1.0
|
N
|
A:LEU639
|
4.1
|
37.5
|
1.0
|
N
|
C:LEU639
|
4.1
|
36.4
|
1.0
|
N
|
D:LEU639
|
4.1
|
46.0
|
1.0
|
N
|
B:LEU639
|
4.1
|
37.1
|
1.0
|
CA
|
A:LEU639
|
4.2
|
37.5
|
1.0
|
CA
|
C:LEU639
|
4.2
|
36.4
|
1.0
|
CA
|
D:LEU639
|
4.2
|
46.0
|
1.0
|
CA
|
B:LEU639
|
4.2
|
37.1
|
1.0
|
HA3
|
C:GLY638
|
4.3
|
35.7
|
1.0
|
HA3
|
D:GLY638
|
4.3
|
46.0
|
1.0
|
HA3
|
A:GLY638
|
4.3
|
37.3
|
1.0
|
HA3
|
B:GLY638
|
4.3
|
36.9
|
1.0
|
CA
|
C:GLY638
|
4.4
|
35.7
|
1.0
|
CA
|
D:GLY638
|
4.4
|
46.0
|
1.0
|
CA
|
A:GLY638
|
4.4
|
37.3
|
1.0
|
CA
|
B:GLY638
|
4.4
|
36.9
|
1.0
|
HA2
|
C:GLY638
|
4.5
|
35.7
|
1.0
|
HA2
|
D:GLY638
|
4.5
|
46.0
|
1.0
|
HA2
|
A:GLY638
|
4.5
|
37.3
|
1.0
|
HA2
|
B:GLY638
|
4.6
|
36.9
|
1.0
|
H
|
A:GLY640
|
4.7
|
42.6
|
1.0
|
H
|
D:GLY640
|
4.7
|
51.6
|
1.0
|
H
|
C:GLY640
|
4.7
|
40.9
|
1.0
|
H
|
B:GLY640
|
4.7
|
41.7
|
1.0
|
H
|
A:LEU639
|
4.8
|
37.5
|
1.0
|
H
|
C:LEU639
|
4.8
|
36.4
|
1.0
|
H
|
D:LEU639
|
4.8
|
46.0
|
1.0
|
H
|
B:LEU639
|
4.9
|
37.1
|
1.0
|
|
Sodium binding site 2 out
of 3 in 8v6m
Go back to
Sodium Binding Sites List in 8v6m
Sodium binding site 2 out
of 3 in the Inactivated-State Cryo-Em Structure of Human TRPV3 in Presence of Tetrahydrocannabivarin (Thcv) in CNW30 Nanodiscs
Mono view
Stereo pair view
|
A full contact list of Sodium with other atoms in the Na binding
site number 2 of Inactivated-State Cryo-Em Structure of Human TRPV3 in Presence of Tetrahydrocannabivarin (Thcv) in CNW30 Nanodiscs within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Na906
b:44.5
occ:1.00
|
HA3
|
A:GLY638
|
3.8
|
37.3
|
1.0
|
HA3
|
D:GLY638
|
3.9
|
46.0
|
1.0
|
HA3
|
C:GLY638
|
3.9
|
35.7
|
1.0
|
HA3
|
B:GLY638
|
3.9
|
36.9
|
1.0
|
O
|
A:ILE637
|
4.6
|
37.5
|
1.0
|
O
|
D:ILE637
|
4.6
|
46.0
|
1.0
|
O
|
C:ILE637
|
4.6
|
35.6
|
1.0
|
O
|
B:ILE637
|
4.6
|
37.1
|
1.0
|
CA
|
A:GLY638
|
4.8
|
37.3
|
1.0
|
CA
|
D:GLY638
|
4.8
|
46.0
|
1.0
|
CA
|
C:GLY638
|
4.8
|
35.7
|
1.0
|
CA
|
B:GLY638
|
4.8
|
36.9
|
1.0
|
|
Sodium binding site 3 out
of 3 in 8v6m
Go back to
Sodium Binding Sites List in 8v6m
Sodium binding site 3 out
of 3 in the Inactivated-State Cryo-Em Structure of Human TRPV3 in Presence of Tetrahydrocannabivarin (Thcv) in CNW30 Nanodiscs
Mono view
Stereo pair view
|
A full contact list of Sodium with other atoms in the Na binding
site number 3 of Inactivated-State Cryo-Em Structure of Human TRPV3 in Presence of Tetrahydrocannabivarin (Thcv) in CNW30 Nanodiscs within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Na907
b:44.5
occ:1.00
|
HE2
|
C:MET677
|
3.3
|
51.1
|
1.0
|
HE2
|
D:MET677
|
3.3
|
63.3
|
1.0
|
HE2
|
A:MET677
|
3.3
|
54.5
|
1.0
|
HE2
|
B:MET677
|
3.3
|
52.6
|
1.0
|
HE1
|
A:MET677
|
3.6
|
54.5
|
1.0
|
HE1
|
C:MET677
|
3.6
|
51.1
|
1.0
|
HE1
|
D:MET677
|
3.6
|
63.3
|
1.0
|
HE1
|
B:MET677
|
3.6
|
52.6
|
1.0
|
HE3
|
C:MET677
|
3.7
|
51.1
|
1.0
|
HE3
|
A:MET677
|
3.7
|
54.5
|
1.0
|
HE3
|
D:MET677
|
3.7
|
63.3
|
1.0
|
CE
|
A:MET677
|
3.7
|
54.5
|
1.0
|
CE
|
C:MET677
|
3.7
|
51.1
|
1.0
|
HE3
|
B:MET677
|
3.7
|
52.6
|
1.0
|
CE
|
D:MET677
|
3.7
|
63.3
|
1.0
|
CE
|
B:MET677
|
3.7
|
52.6
|
1.0
|
HB3
|
A:LEU673
|
4.0
|
46.0
|
1.0
|
HB3
|
D:LEU673
|
4.0
|
53.8
|
1.0
|
HB3
|
C:LEU673
|
4.0
|
43.6
|
1.0
|
HB3
|
B:LEU673
|
4.0
|
44.4
|
1.0
|
HD12
|
A:LEU673
|
4.4
|
46.0
|
1.0
|
HD12
|
D:LEU673
|
4.4
|
53.8
|
1.0
|
HD12
|
C:LEU673
|
4.4
|
43.6
|
1.0
|
HD12
|
B:LEU673
|
4.4
|
44.4
|
1.0
|
HG
|
A:LEU673
|
4.4
|
46.0
|
1.0
|
HG
|
D:LEU673
|
4.5
|
53.8
|
1.0
|
HG
|
C:LEU673
|
4.5
|
43.6
|
1.0
|
HG
|
B:LEU673
|
4.5
|
44.4
|
1.0
|
CB
|
A:LEU673
|
4.9
|
46.0
|
1.0
|
CB
|
D:LEU673
|
4.9
|
53.8
|
1.0
|
CB
|
C:LEU673
|
4.9
|
43.6
|
1.0
|
CB
|
B:LEU673
|
4.9
|
44.4
|
1.0
|
|
Reference:
K.D.Nadezhdin,
A.I.Sobolevsky.
TRPV3 Activation By Different Agonists Accompanied By Lipid Dissociation From the Vanilloid Site To Be Published.
Page generated: Wed Oct 9 13:58:27 2024
|